Research programme: modified CAR-T cell therapies - Umoja Biopharma
Alternative Names: CAR T cell based cancer immunotherapies-Umoja Biopharma; In vivo modified CAR-T cell therapies - Umoja Biopharma; VivoCAR T cellsLatest Information Update: 05 Sep 2023
Price :
$50 *
At a glance
- Originator Umoja Biopharma
- Class Antineoplastics; CAR-T cell therapies; Gene therapies; Immunotherapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer